How long will you live if you have tuberculosis?

  1. Smith A, Miller RF, Story A, Booth HL: A&E department: a missed opportunity for diagnosis of TB?. Thorax. 2006, 61 (4): 364-365. 10.1136/thx.2005.053637.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. World Health Organization: Global tuberculosis control: WHO report 2013. 2013, Geneva, Switzerland: World Health Organization

    Google Scholar 

  3. Oursler KK, Moore RD, Bishai WR, Harrington SM, Pope DS, Chaisson RE: Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors. Clin Infect Dis. 2002, 34 (6): 752-759. 10.1086/338784.

    Article  PubMed  Google Scholar 

  4. Waitt CJ, Squire SB: A systematic review of risk factors for death in adults during and after tuberculosis treatment. Int J Tuberc Lung Dis. 2011, 15 (7): 871-885. 10.5588/ijtld.10.0352.

    Article  CAS  PubMed  Google Scholar 

  5. World Health Organization: Global Tuberculosis Programme. A framework for effective tuberculosis control. WHO/TB/94.179. 1994, Geneva, Switzerland: WHO

    Google Scholar 

  6. Rao VK, Iademarco EP, Fraser VJ, Kollef MH: The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis. Chest. 1998, 114 (5): 1244-1252. 10.1378/chest.114.5.1244.

    Article  CAS  PubMed  Google Scholar 

  7. Borgdorff MW, Veen J, Kalisvaart NA, Nagelkerke N: Mortality among tuberculosis patients in The Netherlands in the period 1993–1995. Eur Respir J. 1998, 11 (4): 816-820. 10.1183/09031936.98.11040816.

    Article  CAS  PubMed  Google Scholar 

  8. Hansel NN, Merriman B, Haponik EF, Diette GB: Hospitalizations for tuberculosis in the United States in 2000: predictors of in-hospital mortality. Chest. 2004, 126 (4): 1079-1086. 10.1378/chest.126.4.1079.

    Article  PubMed  Google Scholar 

  9. Nisar M, Davies PD: Current trends in tuberculosis mortality in England and Wales. Thorax. 1991, 46 (6): 438-440. 10.1136/thx.46.6.438.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Moorman J, Edginton ME: Cause of death of patients on treatment for tuberculosis: a study in a rural South African hospital. Int J Tuberc Lung Dis. 1999, 3 (9): 786-790.

    CAS  PubMed  Google Scholar 

  11. Shen X, Deriemer K, Yuan Z, Shen M, Xia Z, Gui X, Wang L, Mei J: Deaths among tuberculosis cases in Shanghai, China: who is at risk?. BMC Infect Dis. 2009, 17 (9): 95-

    Article  Google Scholar 

  12. Dewan PK, Arguin PM, Kiryanova H, Kondroshova NV, Khorosheva TM, Laserson K, Kluge H, Jakubowiak W, Wells C, Kazionny B: Risk factors for death during tuberculosis treatment in Orel Russia. Int J Tuberc Lung Dis. 2004, 8 (5): 598-602.

    CAS  PubMed  Google Scholar 

  13. Mathew TA, Ovsyanikova TN, Shin SS, Gelmanova I, Balbuena DA, Atwood S, Peremitin GG, Strelis AK, Murray MB: Causes of death during tuberculosis treatment in Tomsk Oblast Russia. Int J Tuberc Lung Dis. 2006, 10 (8): 857-863.

    CAS  PubMed  Google Scholar 

  14. Walpola HC, Siskind V, Patel AM, Konstantinos A, Derhy P: Tuberculosis-related deaths in Queensland, Australia, 1989–1998: characteristics and risk factors. Int J Tuberc Lung Dis. 2003, 7 (8): 742-750.

    CAS  PubMed  Google Scholar 

  15. Xie HJ, Enarson DA, Chao CW, Allen EA, Grzybowski S: Deaths in tuberculosis patients in British Columbia, 1980–1984. Tuber Lung Dis. 1992, 73 (2): 77-82. 10.1016/0962-8479(92)90059-S.

    Article  CAS  PubMed  Google Scholar 

  16. Zafran N, Heldal E, Pavlovic S, Vuckovic D, Boe J: Why do our patients die of active tuberculosis in the era of effective therapy?. Tuber Lung Dis. 1994, 75 (5): 329-333. 10.1016/0962-8479(94)90077-9.

    Article  CAS  PubMed  Google Scholar 

  17. Sterling TR, Zhao Z, Khan A, Chaisson RE, Schluger N, Mangura B, Weiner M, Vernon A: Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors. Int J Tuberc Lung Dis. 2006, 10 (5): 542-549.

    CAS  PubMed  Google Scholar 

  18. Heldal E, Naalsund A, Kongerud J, Tverdal A, Boe J: Deaths from active tuberculosis: can we rely on notification and mortality figures?. Tuber Lung Dis. 1996, 77 (3): 215-219. 10.1016/S0962-8479(96)90003-9.

    Article  CAS  PubMed  Google Scholar 

  19. Hooi LN, Goh KY: A hospital based audit of tuberculosis deaths. Med J Malaysia. 1995, 50 (4): 306-313.

    CAS  PubMed  Google Scholar 

  20. Dye C, Bassili A, Bierrenbach AL, Broekmans JF, Chadha VK, Glaziou P, Gopi PG, Hosseini M, Kim SJ, Manissero D, et al: Measuring tuberculosis burden, trends, and the impact of control programmes. Lancet Infect Dis. 2008, 8 (4): 233-243. 10.1016/S1473-3099(07)70291-8.

    Article  CAS  PubMed  Google Scholar 

  21. Kircher T, Nelson J, Burdo H: The autopsy as a measure of accuracy of the death certificate. N Engl J Med. 1985, 313 (20): 1263-1269. 10.1056/NEJM198511143132005.

    Article  CAS  PubMed  Google Scholar 

  22. Center for Disease Control, Department of Health, Executive Yuan, Taiwan: Taiwan Tuberculosis Control Report 2010. Available at: http://www.cdc.gov.tw

  23. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R: The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994, 149 (3 Pt 1): 818-824.

    Article  CAS  PubMed  Google Scholar 

  24. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, et al: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008, 36 (1): 296-327. 10.1097/01.CCM.0000298158.12101.41.

    Article  PubMed  Google Scholar 

  25. Moniruzzaman A, Elwood RK, Wong H, Kazanjian A, FitzGerald JM: A seventeen-year study of TB diagnosed postmortem in British Columbia, Canada. Am J Respir Crit Care Med. 2009, 179: A5279-

    Google Scholar 

  26. Dyer RA, Chappell WA, Potgieter PD: Adult respiratory distress syndrome associated with miliary tuberculosis. Crit Care Med. 1985, 13 (1): 12-15. 10.1097/00003246-198501000-00004.

    Article  CAS  PubMed  Google Scholar 

  27. Lintin SN, Isaac PA: Miliary tuberculosis presenting as adult respiratory distress syndrome. Intensive Care Med. 1988, 14 (6): 672-674.

    Article  CAS  PubMed  Google Scholar 

  28. Kim YJ, Pack KM, Jeong E, Na JO, Oh YM, Lee SD, Kim WS, Kim DS, Kim WD, Shim TS: Pulmonary tuberculosis with acute respiratory failure. Eur Respir J. 2008, 32 (6): 1625-1630. 10.1183/09031936.00070907.

    Article  CAS  PubMed  Google Scholar 

  29. Pagel W: The evolution of tuberculosis in man. Pulmonary Tuberculosis. Edited by: Pagel W, Simmonds FAH, Norman M. 1964, London: Oxford Medical Publisher, pp 147-pp 161. 4

    Google Scholar 

  30. Angoulvant D, Mohammedi I, Duperret S, Bouletreau P: Septic shock caused by Mycobacterium tuberculosis in an non-HIV patient. Intensive Care Med. 1999, 25 (2): 238-10.1007/s001340050825.

    Article  CAS  PubMed  Google Scholar 

  31. Pene F, Papo T, Burdy-Gulphe L, Cariou A, Piette JC, Vinsonneau C: Septic shock and thrombotic microangiopathy due to Mycobacterium tuberculosis in a nonimmunocompromised patient. Arch Intern Med. 2001, 161 (10): 1347-1348. 10.1001/archinte.161.10.1347.

    Article  CAS  PubMed  Google Scholar 

  32. Michel P, Barbier C, Loubiere Y, Hayon JH, Ricôme JL: Three cases of septic shock due to tuberculosis without HIV pathology. Intensive Care Med. 2002, 28 (12): 1827-1828. 10.1007/s00134-002-1526-9.

    Article  PubMed  Google Scholar 

  33. Achkar JM, Lawn SD, Moosa MY, Wright CA, Kasprowicz VO: Adjunctive tests for diagnosis of tuberculosis: serology, ELISPOT for site-specific lymphocytes, urinary lipoarabinomannan, string test, and fine needle aspiration. J Infect Dis. 2011, 15 (Suppl 4): S1130-S1141.

    Article  Google Scholar 

  • The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/14/5/prepub


Page 2

Underlying cause of death Number (%) Median survival days (range)
TB 43 (17.2) 20 (1–423)
Non-TB 206 (82.7) 55 (1–704)
 Malignancy 98 (39.3) 57 (1–704)
 Bacterial infection 32 (12.8) 55 (1–206)
 CVA 20 (8) 62 (2–544)
 Hepatic failure 12 (4.8) 75 (9–365)
 Renal failure 10 (4) 57 (4–136)
 Cardiovascular disease 9 (3.6) 50 (1–270)
 Autoimmune 6 (2.4) 45 (6–269)
 COPD with respiratory failure 5 (2) 30 (1–88)
 HIV/AIDS 2 (0.8) 31 (17–45)
 Others* 12 (4.8) 87 (7–472)
Total 249 45 (1–704)

  1. COPD: chronic obstructive pulmonary disease; CVA: cerebral vascular disease; HIV: human immunodeficiency virus; AIDS: acquired immunodeficiency syndrome.
  2. *Including 4, 1 and 7 patients that died of accidents, primary pulmonary hypertension, and unknown causes, respectively.